INTRODUCTION: Elderly people are at a higher risk of COVID-19 infection due to their decreased immunity and body reserves, as well as multiple associated comorbidities. Also, course of disease tends to be more severe in case of elderly resulting in higher mortality. MATERIALS AND METHODS: This retrospective study included 757 admitted covid-19 patients in a dedicated tertiary care hospital. The data was collected between December 2021 to March 2022 were analysed for the clinical profile, demographic factors with adverse outcomes in elderly patients. RESULTS: 308 were elderly patients, Mean age was 70.2,males-190(61.7%) females118(38.3%), 267(86.7%) were discharged,40 (13%) died,1(0.3%) went dama.6(1.9%) were asymptomatic,131(42.5%) had mild disease,128(41.6) had moderate disease , 43(14%) had severe disease. 52(16.9%) were vaccinated with covaxin,166(53.9%) were vaccinated with covishield, 90(29.2%) were not vaccinated. Diabetes(62%) and hypertension(53.9) were the major risk factors. Other risk factors included ischemic heart disease, chronic kidney disease, chronic obstructive pulmonary disease, seizures, pulmonary tuberculosis. CONCLUSION: The disease is more severe in patients with comorbidities and unvaccinated when compared to general population. Early diagnosis and individualized therapeutic management should be developed for elderly subjects based on personal medical history and comorbidities .
IJMPR is an international open access source for a high quality and peer reviewed journal in the fields of Medical and Pharmaceutical Sciences. IJMPR publishes research papers across all academic disciplines in the fields of Medical, Pharmaceutical Sciences.